Onconetix, Inc.
ONCONASDAQHealthcare● Active
$1.01
$-0.02(-1.94%)
Market Cap$337369
P/E Ratio—
52W High$382.5
52W Low$0.91
Onconetix, Inc. (ONCO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ONCO · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$6.71
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
✓ 2-Quarter EPS Beat Streak
ONCO reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | -$4505.00 | — | — | — | $0.00B | — |
| — Q2 FY2026 | May 13, 2026 | — | -$6.71 | — | $0.00B | — | — |
| — Q1 FY2026 | Mar 12, 2026 | — | $12.58 | — | $0.00B | — | — |
| — Q4 FY2025 | Nov 13, 2025 | — | -$31.25 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$20.25 | — | $0.00B | — | — |
| — Q2 FY2025 | Jun 12, 2025 | — | $1.06 | — | $0.00B | — | — |
| — Q2 FY2025 | Jun 2, 2025 | — | -$6.40 | — | $0.00B | — | — |
| — Q4 FY2024 | Dec 9, 2024 | — | -$9.49 | — | $0.00B | — | — |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
-$4505.00
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026
EPS Actual
-$6.71
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Mar 12, 2026
EPS Actual
$12.58
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025
EPS Actual
-$31.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025
EPS Actual
-$20.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Jun 12, 2025
EPS Actual
$1.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Jun 2, 2025
EPS Actual
-$6.40
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Dec 9, 2024
EPS Actual
-$9.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2027 | $-35700.00 | $-35700.00 | $-35700.00 | 1 |
| Q2 FY2027 | $-32300.00 | $-32300.00 | $-32300.00 | 1 |
| Q1 FY2027 | $-20400.00 | $-20400.00 | $-20400.00 | 1 |
| Q4 FY2026 | $-34850.00 | $-34850.00 | $-34850.00 | 1 |
| Q3 FY2026 | $-45050.00 | $-45050.00 | $-45050.00 | 1 |
| Q2 FY2026 | $-4505.00 | $-4505.00 | $-4505.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $4.08 | $3.87 | -5.15% |
| — Q1 FY2026 | Mar 12, 2026 | — | $31.30 | $28.60 | -8.63% |
| — Q4 FY2025 | Nov 13, 2025 | — | $137.50 | $122.00 | -11.27% |
| — Q3 FY2025 | Aug 14, 2025 | — | $155.00 | $154.50 | -0.32% |
| — Q2 FY2025 | Jun 12, 2025 | — | $292.50 | $315.00 | +7.69% |
| — Q2 FY2025 | Jun 2, 2025 | — | $331.50 | $340.00 | +2.56% |
| — Q4 FY2024 | Dec 9, 2024 | — | $2,685.00 | $3,018.00 | +12.40% |
| — Q3 FY2024 | Aug 29, 2024 | — | $23,970.00 | $22,780.00 | -4.96% |
Q2 FY2026-5.15%
Report Date
May 13, 2026
EPS Beat/Miss
—
Price Before
$4.08
Price After
$3.87
Q1 FY2026-8.63%
Report Date
Mar 12, 2026
EPS Beat/Miss
—
Price Before
$31.30
Price After
$28.60
Q4 FY2025-11.27%
Report Date
Nov 13, 2025
EPS Beat/Miss
—
Price Before
$137.50
Price After
$122.00
Q3 FY2025-0.32%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$155.00
Price After
$154.50
Q2 FY2025+7.69%
Report Date
Jun 12, 2025
EPS Beat/Miss
—
Price Before
$292.50
Price After
$315.00
Q2 FY2025+2.56%
Report Date
Jun 2, 2025
EPS Beat/Miss
—
Price Before
$331.50
Price After
$340.00
Q4 FY2024+12.40%
Report Date
Dec 9, 2024
EPS Beat/Miss
—
Price Before
$2,685.00
Price After
$3,018.00
Q3 FY2024-4.96%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$23,970.00
Price After
$22,780.00
Beat Rate0 / 8 quarters
Largest Move+12.40% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ONCO ends December
Onconetix, Inc. (ONCO) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-6.71 (in line with the analyst consensus of —). ONCO has beaten EPS estimates for 2 consecutive quarters. The next ONCO earnings date is expected around September 1, 2026.
Each quarter, investors track ONCO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ONCO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ONCO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ONCO earnings · 4 questionsOnconetix, Inc.'s next earnings report is expected around September 1, 2026. ONCO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ONCO historically reports after market close (AMC).
ONCO earnings datewhen is ONCO earningsONCO next earnings datewhen does ONCO report earningsONCO earnings calendar
▸ Source: FMP · Onconetix, Inc. SEC filings · US GAAP · Onconetix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026